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Int J Geriatr Psychiatry. 2018;1–20.Objectives: Medicines play a key role in the lives of people with dementia, primarily
to manage symptoms. Managing medicines is complex for people with dementia and
their family carers and can result in multiple problems leading to harm. We conducted
a systematic review to identify and model medication issues experienced and coping
strategies used by people with dementia and/or family carers.
Methods: Elevengeneral databases and four systematic reviewdatabaseswere searched.
Studies were quality assessed using an established framework and thematically analysed.
Results: Twenty‐one articles were included in this study, and four domains affecting
medication use were identified: cognitive, medication, social and cultural, and knowl-
edge/educational and communication. People with dementia reported medication issues
in all four domains, but few coping strategies were developed. Family carers reported
issues and coping strategies related to the medication and knowledge/educational and
communication domains. Common issueswith regards to knowledge and communication
about medicines remain unresolved. The “voices” of people with dementia appeared
largely missing from the literature so were in‐depth understanding of how, whether,
and in which circumstances coping strategies work in managing medicines.
Conclusions: Medicines management is a complex set of activities and although
current coping strategies exists, these were primarily used by family carers or the per-
son with dementia‐carer dyad. Health and social care practitioners and researchers
should seek to understand in‐depth the “mechanisms of action” of existing coping
strategies and actively involve people with dementia as co‐producers of knowledge
to underpin any further work on medicines management.
KEYWORDS
coping strategies, dementia, family carers, medication management, people with dementia1 | INTRODUCTION
Dementia is a chronic progressive impairment of cognitive function
(including memory, reasoning, decision‐making)1 caused by various- - - - - - - - - - - - - - - - - - - - - - - - - - -
e Creative Commons Attribution Li
tric Psychiatry Published by John W
f this manuscript.conditions affecting the brain, for example Alzheimer's disease and
repeated head trauma.2 Globally, dementia presents a critical chal-
lenge to both health and social care services.3 In the United Kingdom
(UK), an estimated 850 000 people currently live with dementia, and,- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Key points
1. Our study identified and modelled four key domains
that influence the use of medicines: cognitive,
medication, social and cultural, and knowledge/
education and communication.
2. Current coping strategies exists to manage medication
issues but mainly used by family carers or the person
with dementia‐family carer dyad.
3. The “voices” of people with dementia appeared to be
largely missing from reviewed studies.
4. Health and social care practitioners and researchers
should seek to understand in‐depth, the “mechanisms
of action” of coping strategies and actively involve
people with dementia as co‐producers of knowledge
to underpin any further work on medicines
management.
2 LIM AND SHARMEENwith no cure presently available or on the immediate horizon,4 this fig-
ure is projected to increase to two million by 2050.5 The current cost
of dementia in the UK is an estimated £26bn and projected to more
than double to £55bn in 2040.5 The real impact of dementia, however,
extends beyond economics and includes the health, social, and emo-
tional lives of individuals, their families, and wider society.5-9
Although there is currently no cure for dementia, medicines play a
key role in the lives of people with dementia, primarily to manage symp-
toms.10 Some people with dementia may also be prescribed medication
for comorbid health conditions such asType 2 DiabetesMellitus or high
blood pressure.11 Unsurprisingly, given their cognitive problems, man-
aging medication is complex for people with dementia which can result
in “medication errors, medication related hospital admissions, and
dependence on others to assist with medication management tasks”.12
Although non‐adherence to medication is a widespread problem across
conditions, ages, and other demographics, and can be intentional or
unintentional,13 cognitive impairment and dementia have been shown
to specifically impact on medication adherence.
With more than two thirds of people with dementia living in the
community in the UK, and supported in their daily living by around
670 000 family carers,5 there is a need to understand how medicines
are being managed or not, in this setting. Such knowledge is important
so that health and social care practitioners, and researchers, can focus
their work on supporting existing practices and/or designing interven-
tions to enable safe medicines management.
The aim of this systematic review was to identify and model med-
ication issues experienced and coping strategies used by people with
dementia and/or family carers.2 | METHODS
This systematic review is reported according to the Enhancing Trans-
parency in Reporting the Synthesis of Qualitative Research: the
ENTREQ Statement.142.1 | Inclusion criteria
Articles were eligible if they (1) reviewed or were designed to investi-
gate specific challenges or barriers to medication adherence among
people with cognitive impairment or with dementia or Alzheimer's dis-
ease living in their own home; (2) reviewed the role of informal carers
or family carers in medication management for people with dementia;
and (3) reviewed or designed to explore people with dementia, carers,
and/or health care provider's views/perspectives/experiences/rela-
tionships or feelings towards medication use, adherence and manage-
ment, associated barriers and suggested solutions. There were no
restrictions on the type of methodology (qualitative, quantitative, or
mix of both) reported in the study. Only articles published in peer‐
reviewed journals were included. Articles that included study partici-
pants under 65 years old were excluded from the review.2.2 | Search strategy
Eleven general databases (PubMed, EMBASE, Scopus, PsycINFO,
CINAHL, Science Direct, IBSS, Web of Science core collection, TheCochrane Library, Ovid databases, and Google Scholar) and four sys-
tematic review databases (The Campbell Collaboration Library of Sys-
tematic Reviews, Cochrane Reviews, JBI Database of Systematic
Reviews and Implementation Reports, and PROSPERO database) cov-
ering a 32‐year time period from January 1986 to June 2018 were
searched. T.S. and R.L. searched the databases. A specialised librarian
confirmed the comprehensive combination of search terms used.
Searches were limited to the English language.
A comprehensive combination of search terms was used in Pubmed
and Scopus and adapted for all other databases: (“dementia” OR
“Alzheimer's” OR “mild cognitive impairment”) AND (“self‐management”
or “patient managed”) AND (“caregiver role*” OR “carer role*”) AND
(“medication*” OR “prescription*” OR “pharmaceutical*” OR “drug*” OR
“formulation*” OR “dosage form*”) AND (“view*” OR “perception*” OR
“attitude*”) AND (“barrier*” OR “challenge*”) AND (“medication adminis-
tration” OR “medication management” OR “medication use”).2.3 | Screening of studies
Two independent researchers (T.S. and R.L.) screened studies for
inclusion in the study applying a priori inclusion and exclusion criteria.
They screened titles of studies for relevance then abstracts of retained
studies. Full texts of retained references were then obtained and
screened for eligibility. Reference lists of included studies were
searched manually for potentially relevant studies that met the inclu-
sion criteria. Any disagreements were resolved by further discussions
and then consensus.2.4 | Quality assessment
All qualitative studies were quality assessed using an established
appraisal framework15 by T.S. R.L. independently quality assessed a
proportion of these studies. Any disagreements were resolved by dis-
cussion and then consensus. Before conducting a quality assessment
LIM AND SHARMEEN 3of the studies, two screening questions were asked which were
directly related to the research aim:
1. Does the paper report on findings from study/studies on medi-
cine adherence or medicine compliance and cognitive impairment
(CI)/dementia/Alzheimer's disease (AD) AND/OR Patient/carers
experience with medicine adherence or CI or AD or dementia?
2. Is the research relevant to the synthesis topic?
If the answer to either one of these questions was “no,” the study
was excluded. Any disagreements were resolved by discussion and
then consensus. If both answers were “yes,” the appraisal process then
proceeded to the next stage. This next stage involved appraisal ofTABLE 1 Categories and items in the appraisal framework (adapted from
Aim Is there a clear statement of the a
Methodology: Is the methodology (qualitative/qua
In case of a review, is a search stra
Is there a list of keywords provided
Is there a list of inclusion and exclu
Theoretical perspective Is a theoretical perspective identifi
How would you categorise the the
Sampling Is it clear which setting (s) the sam
Is it clear why this setting was cho
Is clear and adequate information g
Is it clear why these samples were
Is it clear how the sample was recr
Is the sample size justified by the a
Is it clear how many people accept
Is it clear why some participants ch
Overall, do you consider the sampl
Data collection Is it clear where the setting of the
Is it clear why that setting was cho
Is it clear how the purpose of the r
Is it clear how the data were collec
Is it clear how the data were recor
Is there evidence of flexibility or an
Is it clear who collected the data?
Overall, do you consider that the d
Data analysis Is it clear how the analysis was don
Is it clear how the categories/them
Is there adequate description of th
Have attempts been made to feed
Have different sources of data abo
Was the analysis repeated by more
Overall, do you consider that the d
Research partnership relations Is it clear whether the researchers
Has the relationship between resea
Findings Please outline the findings here in
What are the key concepts and int
Were the findings explicit and easy
Justification of data interpretation Are sufficient data presented to su
Are quotes numbered/identified?
Do the researchers explain how th
Do the researchers indicate how th
Are negative, unusual, or contradic
Is there adequate discussion of the
Overall, are you confident that all t
Transferability Is there descriptive, conceptual, or
Are the findings of this study trans
Relevance and usefulness Does the study add to knowledge
How important are these findings t
Overall assessment of study What is your overall view of this s
Would you include this study in th
aA “no” answer to these questions were excluded from the study.each paper on the following categories: aim, methodology, theoretical
perspective, sampling, data collection, data analysis, research partner-
ship relations, justification of data interpretation, transferability, rele-
vance and usefulness, and overall assessment of study.15 The
appraisal process involved answering yes/no and elaborations on the
items contained in the categories assessed. See Table 1 for details of
items assessed within each category. Any studies that did not meet
key appraisal criteria were excluded from the study (see Table 2).2.5 | Data extraction
T.S. independently extracted the following information from qualita-
tive studies and systematic reviews: authors, year of publication,Campbell et al, 201115)
ims of the research?a






ple was selected from? (eg, hospital/community)
sen?




ed or refused to take part in the research?
ose not to take part?
ing strategy appropriate to address the aims?a
data collection was?
sen?
esearch was explained and presented to the participants?
ted and why? (eg, interviews/focus groups, etc.)
ded? (eg, audio/video/notes, etc.)
iterative process in the way the research was conducted?
ata were collected in a way that addresses the research aims?a
e?
es were derived from the data?
e analysis?
results back to respondents?
ut the same issue been compared where appropriate (triangulation)?
than one researcher to ensure reliability?
ata analysis was sufficiently rigorous to address the aims?a
critically examined their own role, potential bias and influence?
rchers and participants been adequately considered?
as much detail as possible
erpretations? Please outline in as much detail as possible
to understand?
pport the descriptive findings?
e data presented in the paper were selected from the original sample?
ey developed their conceptual interpretations of what the data contain?
tory cases presented?
evidence both for and against the researchers' interpretations?
he data were taken into account?a
theoretical congruence between this and other work?
ferable to a wider population?
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































LIM AND SHARMEEN 5
6 LIM AND SHARMEENcountry where study was conducted, aim of study, study design and
methodology, study setting, sample size and participant information/
details of studies included (where relevant), and key findings.
Abstracting key findings from qualitative studies has been reported to
be problematic,44 and an approach to resolve this problem is to include
all text included under “results” or “findings,” the approach taken in this
study. The same approach was taken for systematic reviews. In addi-
tion, quotes and results cited in systematic reviews were checked for
their source andmatched to the list of included studies. Full text articles
of references which were not in the list were then obtained, screened
for eligibility, quality assessed, and relevant data extracted.
2.6 | Data synthesis
Due to the heterogeneity of study designs, it was not possible to
use a meta‐analysis approach to analyse quantitative findings. A the-
matic synthesis44 with a framework approach45-47 was used instead.
A framework approach, a form of thematic analysis, was appropriate
because the research question was focused on a targeted area as
opposed to very broad or abstract topics47—that of challenges to
medication management for people living with dementia and their
informal carers. It was also important to ensure the context of each
individual study was not lost and a framework approach enables
comparison across and within individual cases or studies within the
analysis process.45,47 In addition, the framework matrix that was
formed as part of the analysis process provides a systematic model
for mapping and analysing data which is important for the two
researchers (R.L. and T.S.) undertaking the review, who are from
two different disciplinary backgrounds.45 The following steps were
undertaken in the synthesis45-47:F1. Familiarisation: researchers read through extracted data from an
initial sample of studies (approximately 3‐5). Key ideas were iden-
tified from each of these studies. During this process, recurrent
themes were identified.IGURE 1 Article selection for inclusion in the study2. Develop a thematic framework: a framework was then con-
structed based on the research aims and the recurrent themes
identified during the familiarisation process.
3. Indexing: the thematic framework was then applied consistently
to all study data.
4. Charting: data from the original studies were then lifted and
placed within the appropriate thematic categories within the the-
matic framework.
5. Mapping: the final stage in the process is to interpret and map the
range, polarities, and similarities within the data.
Using a framework approach, the focus was on understanding the
breadth and depth of challenges reported in studies rather than the
frequency of these problems. The approach to the synthesis did not
emphasise weighing data for example through counting how many
times a particular challenge was reported. Each reported challenge
was considered to be unique and of equal significance. If the same
challenge was reported multiple times in multiple papers including sys-
tematic reviews, it was still included once in the synthesis.
T.S. and R.L. conducted the analysis through extensive and itera-
tive discussions. Any disagreements were resolved by further discus-
sions and then consensus.2.7 | Ethical considerations
Ethical approvals were not required as the study was a systematic
review of peer‐reviewed studies.3 | RESULTS
3.1 | Study characteristics
Figure 1 shows the article selection process. Following quality assess-
ment of studies (shown inTable 2), a total of 21 articles were included
LIM AND SHARMEEN 7in this study: 12 empirical studies and nine reviews (see
Table 3). Of the 12 empirical studies, eight used qualitative methods
of enquiry,18,22,25,27,32,34,36,43 two used mixed methods (a combination
of qualitative and quantitative approaches),19,20 and two followed
cross‐sectional study designs using quantitative methodology.27,39
Six studies were carried out in North America (five in the United
States and one in Canada), three in Australia, and five studies were
conducted in UK. Six of the systematic reviews included both quanti-
tative and qualitative studies,23,31,33,35,38,40 two only selected quanti-
tative studies for review,12,26 and one was conducted only on
qualitative studies.30
The key characteristics and main findings from included studies
are presented inTable 3. In eight of the 12 empirical studies, the study
design included people with dementia and family carers as partici-
pants.19,20,22,25,27,28,36,43 However, only four of these studies
interviewed matching dyads (people with dementia with their family
carers).19,20,36,43 Seven studies included people with demen-
tia.20,22,25,27,36,39,43 The study design in these studies included semi‐
structured interviews (n = range 4‐11 participants),25,27,36,43 self‐
reporting of beliefs and barriers to medication non‐adherence
(n = 96),39 assessment of performance on medication management
tasks (n = 27),20 and focus group (n = 19).22 One study39 compared
the frequencies of barriers to medication adherence between people
with dementia and adults with no cognitive issues.3.2 | Key domains affecting medication use
Secondary analysis based on the synthesis of primary accounts
reported in the included studies identified four domains affecting the
use of medication as reported by people with dementia and/or their
carers: cognitive, medication, social and cultural, and knowledge/edu-
cational and communication (see Figure 2 and supporting data and
quotes in Table 4).
The cognitive domain includes factors such as the impairment of
cognition, typically involving problems related to memory and at least
one other cognitive domain (language, visuospatial, executive func-
tion) as reported by people with dementia and/or carers.12,23,25,27,34
In the medication domain, factors relating to obtain and use of medi-
cines,27,36,38,43 risks of experiencing medication error,27 concerns
about medication and patient safety,27 and the complexity of the med-
icine regimen25,27 were identified. Factors relating to the lack of
appropriate support and help,25 caregiver availability,25,40 and living
alone23,25,33 formed part of the social and cultural domain. The knowl-
edge/educational and communication domain represent the factors
related to difficulty in understanding complex regimen27,36 and ability
to make clinical judgement in times of need.27,36
People with dementia can be affected by the changes in any of
these four domains due to the inter‐relationships among the domains.
A decline in cognitive ability affects people with dementia's ability to
plan, execute, manage, and organize medicine‐related tasks.23,33,34
Issues in the cognitive domain can result in confusion and lack of
insight27,34,36 which in turn leads to risks of experiencing medication
errors (underdose, overdose, wrong drug), unintentional non‐adher-
ence, or adverse events23,27,34 (in the medication domain). This dem-
onstrates a link between the cognitive and medication domain.Health literacy and ability to understand and acquire medicine knowl-
edge about treatment indication and directions have a direct impact
on medication use27,36,40 showing a link between the knowledge/edu-
cation and communication domain, and the medication domain. The
inter‐relationships between socio‐cultural, education/knowledge, and
cognitive domain are linked with intrinsic factors such as motivation
(to learn new medication regimen/treatment)27,30,36; attitudes, beliefs,
and desire to maintain independence and self‐management of medi-
cines27; motivation to acquire knowledge or awareness/insight into
cognitive and functional impairment and acceptance of the disease
and willingness to accept help/use of adaptive strategies.3.3 | Issues related to medication use and coping
strategies
Table 4 provides a summary of specific issues to medication use as
reported by people with dementia and family carers alongside any
coping strategies reported to address them. Exemplars in the form of
quotes from included studies are also included in Table 4 to show
how challenges, coping strategies, and the overall domains affecting
medication use were derived. People with dementia reported issues
in all four domains (cognitive, medication, social and cultural, and
knowledge/educational and communication). However, there were
few solutions that they have employed to aid medication use. Most
of the challenges reported by family carers related to the medication
and knowledge/educational and communication domains; these were
matched with corresponding solutions. Table 4 also highlight chal-
lenges faced by the dyads and the reactive strategies that they have
used are similar in nature (ie, cognitive and maintaining continuous
supply of medication). There were however challenges faced by both
people with dementia and family carers that remain unresolved,
eg, managing challenges relating to communicating with people with
dementia (for family carers) and knowledge about indication of
prescribed medication (for people with dementia).4 | DISCUSSION
To our knowledge, this is the first systematic review that identified
and modelled a range of system factors influencing the overall man-
agement use of medicines and matching coping strategies within four
inter‐related system domains, as expressed by people with dementia
and/or family carers. Although there are existing systematic reviews
investigating medication issues, they have focused specifically on
medication non‐adherence,26 the overall health care experiences of
people with dementia and their caregivers (not specific to medication
management),30 and the relationship between medication non‐adher-
ence and cognitive domains (eg, memory and executive functioning).12
This current study modelled medication management issues and chal-
lenges within the wider medication management system (not
restricted to the person or dyad, including but not restricted to factors
affecting/associated with medication non‐adherence, health care sys-
tem‐level issues related to medicines management), and mapped the
interconnectivity among/between other system domains. It is impor-






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































12 LIM AND SHARMEEN
FIGURE 2 Domains and factors affecting medication use [Colour figure can be viewed at wileyonlinelibrary.com]
LIM AND SHARMEEN 13individual parts/domains because it is now widely acknowledged that
interventions developed to manage medicines require a whole sys-
tems view.
Our study confirms that medication management comprised a
complex range of activities for the person with dementia‐carer dyad.
This finding is in line with existing studies that highlighted medication
management as a complex extensive concept that requires a combina-
tion of management and organization skills, clinical knowledge, and
understanding of medicine safety.31,34,43
Unsurprisingly, our study identified wide‐ranging system issues
relating to medicines management and some corresponding coping
strategies, as experienced by people with dementia and/or family
carers. These were categorised into cognitive, medication, social and
cultural, and knowledge/educational and communication domains.
Analysis of the meta‐data from the studies included in this review
identified similarities between people with dementia and family carers
in their experiences of difficulties surrounding medicines management.
Whilst these similarities could be attributed to “ageing” [while], other
studies suggested the family carers' role as advocates for people with
dementia to be a key factor.23,38,39,48
The complexities of managing medicines increases with the pro-
gression of dementia. Most of the strategies employed by people with
dementia and/or family carers at the initial stages of dementia were
reactive in nature. Family carers played a crucial compensating role
in managing medicines as the disease progresses, and they are devel-
oping proactive strategies to manage medicines.27 Progressive deteri-
oration of the person with dementia's sight, cognition, and dexterity
poses challenges. Declining cognitive function makes understanding
and retaining medication knowledge or remembering and learning
new medicine regimen difficult. In these circumstances, it appears that
people with dementia transfer their control of managing medication to
their family carer.20,23 The family carer eventually takes on the role of
organization and management of medicines, and the responsibility of
administering the prescribed medication which contributes to stress
and a reduction in their quality of life.8,27,49-51 There appears to beno available data on how people with dementia give up their control,
how the transition happens, and what types of challenges, eg, emo-
tional (giving control to someone else, adjusting with independence/
sacrificing independence) and socio‐cultural factors a person faces
and what type of coping mechanism are used. In addition, there is very
little documented in the published literature on the challenges family
carers faced during this transition phase especially the emotional
costs, the communications gaps, and complex ethical decision‐making
burdens they had to take on behalf of the people with dementia.
With declining cognitive ability, people with dementia are less
likely to use internal memory strategies to aid with medication admin-
istration.23 Studies included in this review25,27,32,36 found that recall of
repetitive tasks such as medication administration could be supported
by connecting the activity to environmental cues, a strategy that was
mentioned by both people with dementia and their family carers. Dose
administration aids, specifically the Webster‐pak, are common exter-
nal memory strategies for older people52-55 and people with dementia
used these more frequently than older people.27 Whilst there is docu-
mented evidence that carers have developed coping strategies to help
with the organisation of medication for example in ordering, collecting,
and storing of medication, there are still gaps to managing cognitive
challenges, eg, communicating with people with dementia or commu-
nicating with confused uncooperative care recipient highlighting the
need to investigate these in future studies.
There appeared to be no coping strategy for managing medication
issues such as knowledge about indication of prescribed medication in
this study. It is also interesting to note that none of the studies in this
review reported support or coping strategies for people with dementia
to self‐manage their medicines. However, other supporting strategies
are in place such as de‐prescribing (withdrawing of medications) which
has been undertaken with some success56,57 and the use of home care
agencies to help the person with dementia, mainly with their daily liv-
ing activities with limited roles in managing medicines. There is also
greater recognition and advocacy in involving people with dementia




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































LIM AND SHARMEEN 17
18 LIM AND SHARMEENmedicines is scarce. This presents a need for further research into this
area given that many people with dementia live alone in their own
homes.
Despite current knowledge of existing coping strategies, there
appears to be little insight or in‐depth understanding as to how,
whether, and in which circumstances these strategies work for people
with dementia and/or family carers and any adjustments they make to
manage medicines. For example, there is limited literature reporting
how and when people with dementia and/or family carers decide to
switch from internal memory strategies to external adaptive strategies
and, whether and in which circumstances these strategies are effec-
tive in managing medication. Future studies are needed to investigate
in‐depth the “mechanisms of action” of medication management strat-
egies currently employed by people with dementia and/or family
carers using realist approaches61,62 to inform recommendations for
managing medicines safety in people's own homes.
Despite the inclusion of people with dementia in some of the
studies reviewed in this study, their perspectives towards medicine
use such as medication issues and coping strategies were largely miss-
ing from the study results; their “voices” did not seem to be repre-
sented compared with those of family carers. This is puzzling and
could be due to multiple factors such as the study design and how
research was conducted with people with dementia. Several studies
report efforts to address the issue of study design by carefully consid-
ering inclusive approaches that enables people with dementia, largely
those with early stages of dementia, to contribute to research in a
meaningful way.63-66 However, long‐standing ethical and methodolog-
ical issues such as providing informed consent, doubts about the reli-
ability of their accounts, and communication problems67-70 in those
with later stages of dementia still require further discussion and test-
ing. Active and real involvement of people at different stages of
dementia in research is crucial to enable evidence‐based practice or
interventions designed to improve management of medicines by peo-
ple with dementia and/or carers living in their own homes. Future
studies should strongly consider taking forward suggestions for includ-
ing people with dementia in research, such as those proposed by
Alzheimer's Europe70 that advocates an inclusive approach to research
by entering into a collaborative relationship with people with demen-
tia and their advocates and also providing the necessary infrastructure
to enable such collaboration to take place effectively. Research con-
ducted within this culture and practice could be more conducive and
effective in exploring people with dementia's perspectives and lived
experiences on medication related beliefs, strategies, preferences,
and routines, along with the needs of carers, so that an individualised
and person‐centred approach can be developed and used in practice.4.1 | Study limitations
Literature searches were limited to the English language and excluded
grey literature. The studies reviewed were also largely exploratory in
nature, and few specified any theoretical underpinnings to their study
design. The two researchers involved in the analysis were from phar-
macy/health system/human factors and bio‐cultural and medical
anthropology backgrounds which may not represent a wide range of
perspectives when interpreting findings from studies. To address thislimitation, the findings of the systematic review were also discussed
with a group of stakeholders (who formed the project advisory group
of the wider study within which this systematic review was con-
ducted) that included people living with dementia, family carers, com-
munity pharmacist, general practitioner, charity representative, and
academics, and presented at an international dementia conference.71
Overall, the findings resonated with people's personal experiences
and further comments were made regarding the lack of appreciation
of the “social” domain in everyday clinical practice. Although individual
issues identified in this study were not new, feedback received
highlighted the systematic, conceptual, and visual way in which medi-
cation management issues/domains were presented and the intercon-
nection between domains to be an important addition to the current
body of knowledge.5 | CONCLUSION
In this study, we identified and modelled wide‐ranging system factors
influencing the use of medicines, as expressed by people with demen-
tia and/or family carers. Medicines management is a complex set of
activities and although current coping strategies exists to manage
medication issues, these were primarily used by family carers and/or
the person with dementia‐carer dyad. There also appear to be few
strategies to support cognitive issues such as communication and
understanding indications of prescribed medicines. In‐depth under-
standing of how, whether, and in which circumstances coping strate-
gies work for people with dementia and/or carers were largely
missing. Although some studies have included people with dementia
in their studies, the real “voices” of people with dementia appeared
to be largely missing from the literature. Future studies should (1)
investigate in‐depth the “mechanisms of action” of coping strategies
employed by people with dementia and/or carers and (2) include peo-
ple with dementia as co‐producers of research knowledge (ie, doing
research collaboratively as opposed to doing research on people with
dementia) to underpin further work on developing interventions to
enable safe medicines management by people with dementia and/or
the person with dementia‐carer dyad in their own homes.AUTHORS' CONTRIBUTIONS
R.L. made a substantial contribution to the conception and design of
the work, the interpretation of data, drafting of the paper, and super-
vision of the study. T.S. made a substantial contribution to the design
of the work, the acquisition and interpretation of data, and drafting of
the paper. All authors approved the final version of the paper.
FUNDING
The study was part of a study funded by the Wellcome Trust Seed
Award in Humanities and Social Science awarded to R.L. (grant num-
ber 108320/Z/15/Z). The funders had no role in the design of the
study, the collection and analysis of the data, or in the preparation
of the manuscript.
LIM AND SHARMEEN 19CONFLICT OF INTEREST
None declared
ORCID
Rosemary H. Lim http://orcid.org/0000-0003-1705-1480
Taniya Sharmeen http://orcid.org/0000-0002-4600-0001
REFERENCES
1. Alzheimer's Society UK. What is Alzheimer's disease? London.
2014; https://www.alzheimers.org.uk/site/scripts/documents_info.
php?documentID=100 (27 May 2016, date last accessed).
2. McKee A, Stern R, Nowinski C, et al. The spectrum of disease in
chronic traumatic encephalopathy. Brain. 2013;136(1):43‐64.
3. Prince M, Wimo A, Guerchet M, et al. World Alzheimer's Report 2015,
The Global Impact of Dementia: An analysis of prevalence, incidence,
cost and trends. London. 2015; https://www.alz.co.uk/research/
WorldAlzheimerReport2015.pdf (6 July 2017, date last accessed).
4. Cummings J, Aisen P, DuBois B, et al. Drug development in Alzheimer's
disease: the path to 2025. Alzheimers Res Ther. 2016;20(8):39. https://
doi.org/10.1186/s13195‐016‐0207‐9
5. Prince M, Knapp M, Guerchet M, et al. Dementia UK: Update Second
Edition. London. 2014; http://eprints.lse.ac.uk/59437/1/Dementia_
UK_Second_edition_‐_Overview.pdf (6 July 2017, date last accessed).
6. Lewis F, Karlsberg Schaffer S, Sussex J, et al. Trajectory of dementia in
the UK—making a difference. London. 2014; file:///C:/Users/
qv906165/Downloads/401%20‐%20Trajectory_dementia_UK_2014.
pdf (6 July 2017, date last accessed).
7. Farina N, Page T, Daley S, et al. Factors associated with the quality of
life of family carers of people with dementia: a systematic review.
Alzheimers Dement. 2017;13(5):572‐581.
8. Cooper C, Balamurali T, Livingston G. A systematic review of the prev-
alence and covariates of anxiety in caregivers of people with dementia.
Int Psychogeriatr. 2007;19(02):175‐195.
9. Connell J, Page S, Sheriff I, Hibbert J. Business engagement in a civil
society: transitioning towards a dementia‐friendly visitor economy.
Tour Manag. 2017;61:110‐128.
10. Donegan K, Fox N, Black N, Livingston G, Banerjee S, Burns A. Trends
in diagnosis and treatment for people with dementia in the UK from
2005‐2015: a longitudinal retrospective cohort study. Lancet.
2017;2(3):e149‐e156.
11. Browne J, Edwards DA, Rhodes KM, Brimicombe DJ, Payne RA. Asso-
ciation of comorbidity and health service usage among patients with
dementia in the UK: a population‐based study. BMJ Open. 2017;7(3):
e012546. https://doi.org/10.1136/bmjopen‐2016‐012546
12. Smith D, Lovell J, Weller C, et al. A systematic review of medication non‐
adherence in persons with dementia or cognitive impairment. PLoS One.
2017;12(2):e0170651. https://doi.org/10.1371/journal.pone.0170651
13. National Institute for Health and Care Excellence. Clinical Guidelines
and Evidence Review for Medicines Adherence: involving patients




2017, date last accessed).
14. Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transpar-
ency in reporting the synthesis of qualitative research: ENTREQ. BMC
Med Res Methodol. 2012;12(1):181.
15. Campbell R, Pound P, Morgan M, et al. Evaluating meta‐ethnography:
systematic analysis and synthesis of qualitative research. Health
Technol Assess. 2011;15(43):1‐164. https://doi.org/10.3310/hta15430
16. Ryan A. Medication compliance and older people: a review of the liter-
ature. Int J Nurs Stud. 1999;36(2):153‐162.17. Fox K, Ladson H, Levkoff S. Take up the caregiver's burden: stories of
care for urban African American elders with dementia. Cult Med Psychi-
atry. 1999;23(4):501‐529.
18. Travis S, Bethea L, Winn P. Medication administration hassles reported
by family caregivers of dependent elderly persons. J Gerontol. 2000;55:
M412‐M417.
19. Smith F, Francis SA, Gray N, Denham M, Graffy J. A multi‐centre sur-
vey among informal carers who manage medication for older care
recipients: problems experienced and development of services. Health
Soc Care Community. 2003;11(2):138‐145.
20. Cotrell V, Wild K, Bader T. Medication management and adherence
among cognitively impaired older adults. J Gerontol Soc Work. 2006;
47(3‐4):31‐46.
21. Francis S, Smith F, Gray N, et al. Partnerships between older people and
their carers in the management of medication. Int J Older People Nurs.
2006;1(4):201‐207. https://doi.org/10.1111/j.1748‐3743.2006.00032.x
22. Lindstorm H, Smyth K, Sami S, et al. Medication use to treat memory loss
in dementia: perspectives of persons with dementia and their caregivers.
Dementia. 2006;5(1):27‐50. https://doi.org/10.1177/1471301206059753
23. Arlt S, Lindner R, Rösler A, von Renteln‐Kruse W. Adherence to medi-
cation in patients with dementia: predictors and strategies for
improvement. Drugs Aging. 2008;25(12):1033‐1047. https://doi.org/
10.2165/0002512‐200825120‐00005
24. Duane F, While C, Beanland C Susan Koch Making medicines manage-
able: a culturally and linguistically diverse perspective: Royal District
Nursing Service. 2011; https://www.rdns.com.au/wp‐content/
uploads/public/files/files/Making%20Medicines%20Manageable%
20report%202011.pdf (20 March 2018, date last accessed)
25. Kaasalainen S, Dolovich L, Holbrook A, et al. The process of medication
management for older adults with dementia. J Nurs Healthc Chronic Illn.
2011;3(4):407‐418.
26. Campbell NL, Boustani MA, Skopelja EN, Gao S, Unverzagt FW,
Murray MD. Medication adherence in older adults with cognitive
impairment: a systematic evidence‐based review. Am J Geriatr
Pharmacother. 2012;10(3):165‐177. https://doi.org/10.1016/j.amjopharm.
2012.04.004
27. While C, Duane F, Beanland C, Koch S. Medication management: the
perspectives of people with dementia and family carers. Dementia.
2012;12(6):734‐750. https://doi.org/10.1177/1471301212444056
28. Erlen J, Lingler J, Sereika S, Happ M, Tang F. Characterizing caregiver
mediated medication management in patients with memory loss. J
Gerontol Nurs. 2013;39(4):30‐39.
29. Wheeler K, Roberts M, Neiheisel M. Medication adherence part two:
predictors of nonadherence and adherence. J Am Assoc Nurse Pract.
2014;26(4):225‐232. https://doi.org/10.1002/2327‐6924.12105
30. Prorok J, Horgan S, Seitz D. Health care experiences of people with
dementia and their caregivers: a meta‐ethnographic analysis of qualita-
tive studies. Can Med Assoc J. 2013;185(14):E669‐E680. https://doi.
org/10.1503/cmaj.121795
31. Gillespie R, Mullan J, Harrison L. Managing medications: the role of
informal caregivers of older adults and people living with dementia. A
review of the literature. J Clin Nurs. 2014;23(23‐24):3296‐3308.
https://doi.org/10.1111/jocn.12519
32. Poland F, Mapes S, Pinnock H, et al. Perspectives of carers on medica-
tion management in dementia: lessons from collaboratively developing
a research proposal. BMC Res Notes. 2014;7(1):463.
33. Elliott RA, Goeman D, Beanland C, Koch S. Ability of older people with
dementia or cognitive impairment to manage medicine regimens: a nar-
rative review. Curr Clin Pharmacol. 2015;10(3):213‐221.
34. Gillespie R, Harrison L, Mullan J. Medication management concerns of
ethnic minority family caregivers of people living with dementia.
Dementia. 2015;14(1):47‐62.
35. Hudani ZK, Rojas‐Fernandez CH. A scoping review on medication
adherence in older patients with cognitive impairment or dementia.
20 LIM AND SHARMEENRes Social Adm Pharm. 2015; pii: S1551–7411;(15):00271‐00275.
https://doi.org/10.1016/j.sapharm.2015.11.011
36. Smith F, Grijseels MS, Ryan P, Tobiansky R. Assisting people with
dementia with their medicines: experiences of family carers. Int J
Pharm Pract. 2015;23(1):44‐51. https://doi.org/10.1111/ijpp.12158
37. Snyder C, Fauth E, Wanzek J, et al. Dementia caregivers' coping strat-
egies and their relationship to health and well‐being: the Cache County
study. Aging Ment Health. 2015;19(5):390‐399.
38. Alsaeed D, Jamieson E, Gul M, et al. Challenges to optimal medicines
use in people living with dementia and their caregivers: a literature
review. Int J Pharm. 2016;512(2):396‐404. https://doi.org/10.1016/J.
IJPHARM.2015.12.050
39. Campbell NL, Zhan J, Tu W, et al. Self‐reported medication adherence
barriers among ambulatory older adults with mild cognitive impair-
ment. Pharmacotherapy. 2016;36(2):196‐202. https://doi.org/
10.1002/phar.1702
40. Aston L, Hilton A,MoutelaT, Shaw R, Maidment ID. Exploring the evidence
base for how people with dementia and their informal carers manage their
medication in the community: a mixed studies review. BMC Geriatr 2007.
2017;17(242). https://doi.org/10.1186/s12877‐017‐0638‐6
41. George N, Steffen A. Predicting perceived medication‐related hassles
in dementia family caregivers. Dementia. 2017;16(6):797‐810.
42. Lindauer A, Sexson K, Harvath TA. Medication management for people
with dementia. Am J Nurs. 2017 May;117(5 Suppl 1):S17‐S21. https://
doi.org/10.1097/01.NAJ.0000516389.35634.84
43. Maidment ID, Aston L, MoutelaT, Fox CG, Hilton A. A qualitative study
exploring medication management in people with dementia living in the
community and the potential role of the community pharmacist. Health
Expect. 2017;20(5):929‐942. https://doi.org/10.1111/hex.12534
44. Thomas J, Harden A. Methods for the thematic synthesis of qualitative
research in systematic reviews. BMC Med Res Methodol. 2008;8(1):45.
https://doi.org/10.1186/1471‐2288‐8‐45
45. Goodyear‐Smith F, York D, Petousis‐Harris H, et al. Recruitment of
practices in primary care research: the long and the short of it. Family
Practice 2009; cmp015.
46. Ritchie J, Lewis J. Qualitative Research Practice: A Guide for Social Sci-
ence Students and Researchers. London: Sage; 2003.
47. Pope C, Ziebland S, Mays N. Analysing qualitative data. British Med J.
2000;320(7227):114‐116. https://doi.org/10.1136/bmj.320.7227.114
48. Maidment I, Fox C, Boustani M, Katona C. Medication management—
the missing link in dementia interventions. Int J Geriatr Psychiatry.
2012;27(5):439‐442. https://doi.org/10.1002/gps.2745
49. Schoenmakers B, Buntinx F, Delepeleire J. Factors determining the
impact of care‐giving on caregivers of elderly patients with dementia.
A systematic literature review. Maturitas. 2010;66(2):191‐200.
50. Crellin N, Orrell M, McDermott O, Charlesworth G. Self‐efficacy and
health‐related quality of life in family carers of people with dementia:
a systematic review. Aging Ment Health. 2014;18(8):954‐969.
51. de Oliveira DC, Vass C, Aubeeluck A. Ageing and quality of life in fam-
ily carers of people with dementia being cared for at home: a literature
review. Qual Prim Care. 2015;23:18‐30.
52. Marek K, Antle L. Medication management of the community dwelling
older adult. In: Hughes R, ed. Patient Safety and Quality: An Evidence‐
Based Handbook for Nurses. Rockville, MD: Agency for Healthcare
Research and Quality; 2006.
53. Schlenk E, Dunbar‐Jacob J, Enberg S. Medication non‐adherence
among older adults: a review of strategies and interventions for
improvement. J Gerontol Nurs. 2004;30(7):33‐43.
54. Thobaben M. How to avoid medication errors: six tips for clients/care-
givers. Home Health Care Manag Prac. 2009;21(5):363‐365.
55. Thwaites J. Practical aspects of drug treatment in elderly patients with
mobility problems. Drugs Aging. 1999;14(2):105‐114.56. Reeve E, Bell S, Hilmer S. Barriers to optimising prescribing and
deprescribing in older adults with dementia: a narrative review. Curr
Clin Pharmacol. 2015;10(3):168‐177.
57. Ní Chróinín D, Ní Chróinín C, Beveridge A. Factors influencing
deprescribing habits among geriatricians. Age Ageing. 2015;44(4):
704‐708. https://doi.org/10.1093/ageing/afv028.
58. Rodgers P. Co‐designing with people living with dementia. CoDesign.
2018;14(3):188‐202. https://doi.org/10.1080/15710882.2017.1282527
59. Niedderer K, Tournier I, Coleston‐Shields DM, et al. Designing with
and for people with dementia: developing a mindful interdisciplinary
co‐design methodology. In: Seventh International Conference of the
International Association of Societies of Design Research (IASDR), 1–
3 November 2017, Cincinnati, USA
60. Treadaway C, Taylor A. & Fennell J. Compassionate creativity: co‐
design for advanced dementia. Proceedings of the Fifth International
Conference on Design Creativity (ICDC2018) Bath, UK, January 31st
– February 2nd 2018
61. Pawson R, Tilley N. Realistic Evaluation. London, U.K.: Sage; 1997.
62. Wong G. Getting to grips with context and complexity—the case for
realist approaches. Gac Sanit. 2018;32(2):109‐110.
63. Bamford C, Bruce E. Successes and challenges in using focus groups
with older people with dementia. In: Wilkinson H, ed. The Perspectives
of People with Dementia. Research Methods and Motivations. London,
Philadelphia: Jessica Kingsley Publishers; 2002:139‐164.
64. Brooks J, Savitch N, Gridley K. Removing the ‘gag’: involving people
with dementia in research as advisers and participants. Soc Res Pract.
2017;3‐14.
65. The University of Edinburgh and the Scottish Dementia Working Group
Research Sub‐group. Core principles for involving people with dementia
in research. Edinburg. 2013. https://coreprinciplesdementia.files.
wordpress.com/2014/05/dementia‐a5‐booklet.pdf Accessed: March 5,
2018.
66. Sharmeen T, Lim R. Can people living with dementia co‐produce
research data about their management of medicines? Alzheimers
Dement. 2017;13(7) Supplement):1562. https://doi.org/10.1016/j.
jalz.2017.07.713
67. Dewing J. From ritual to relationship: a person‐centred approach to
consent in qualitative research with older people who have a dementia.
Dementia. 2001;1(2):157‐171.
68. Hubbard G, Downs M, Tester S. Including older people with dementia
in research: challenges and strategies. Aging Ment Health.
2003;7(5):351‐362. https://doi.org/10.1080/1360786031000150685
69. Hellström I, Nolan M, Nordenfelt L, Lundh U. Ethical and methodolog-
ical issues in interviewing persons with dementia. Nurs Ethics.
2007;14(5):608‐619.
70. Gove D, Diaz‐Ponce A, Georges J, et al. Alzheimer Europe's position on
involving people with dementia in research through PPI (patient and
public involvement). Aging Ment Health. 2018;22(6):723‐729. https://
doi.org/10.1080/13607863.2017.1317334
71. SharmeenT, Lim R. A systematic review of the management of medicines
by people living with dementia in their own homes and their family carers:
issues faced and strategies adopted. Alzheimers Dement. 2017;13(7)
Supplement):1568. https://doi.org/10.1016/j.jalz.2017.07.727How to cite this article: Lim RH, SharmeenT. Medicines man-
agement issues in dementia and coping strategies used by peo-
ple living with dementia and family carers: A systematic
review. Int J Geriatr Psychiatry. 2018;1–20. https://doi.org/
10.1002/gps.4985
